Unione Europea - italiano - EMA (European Medicines Agency)

almirall, s.a. - tirbanibulin - cheratosi, attinico - antibiotici e chemioterapici per uso dermatologico - klisyri is indicated for the field treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (olsen grade 1) of the face or scalp in adults.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

almirall ag - tirbanibulinum - salve - tirbanibulinum 10 mg, glyceroli monostearas 40-55, propylenglycolum 890 mg, ad unguentum pro 1 g. - aktinische keratose - synthetika